Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desloratadine 5mg tablets
0304010ABAAAAAA
|
Desloratadine | Desloratadine | Respiratory System | 38,928 |
|
Neoclarityn 5mg tablets
0304010ABBBAAAA
|
Neoclarityn | Desloratadine | Respiratory System | 4,504 |
|
Desloratadine 2.5mg/5ml oral solution sugar free
0304010ABAAADAD
|
Desloratadine | Desloratadine | Respiratory System | 2,374 |
|
Neoclarityn 2.5mg/5ml oral solution
0304010ABBBACAD
|
Neoclarityn | Desloratadine | Respiratory System | 263 |
|
Desloratadine 2.5mg/5ml oral solution
0304010ABAAABAB
|
Desloratadine | Desloratadine | Respiratory System | No data available |
|
Midetorin 2.5mg/5ml oral solution (Actavis)
0304010ABBDAAAD
|
Midetorin | Desloratadine | Respiratory System | No data available |
|
Midetorin 2.5mg/5ml oral solution (Arrow)
0304010ABBDABAD
|
Midetorin | Desloratadine | Respiratory System | No data available |
|
Neoclarityn 2.5mg/5ml syrup
0304010ABBBABAB
|
Neoclarityn | Desloratadine | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.